Yangxinshi tablet

DRUG3 trials

Sponsors

Dongzhimen Hospital, Beijing, Shandong First Medical University, SPH Qingdao Growful Pharmacetical Co.,Ltd

Conditions

Cardiac DysfunctionChronic Coronary SyndromeCoronary Heart Disease

Phase 4

Effect of Yangxinshi Tablet on Exercise Tolerance in Patients With Chronic Coronary Syndrome（MET STUDY）

Dongzhimen Hospital, BeijingChronic Coronary Syndrome

Start: 2023-11-08End: 2025-12-31Target: 120Updated: 2023-12-18

Yangxinshi Tablet Intervention for Exercise Capacity in Patients With Chronic Coronary Syndrome

RecruitingNCT06171061

Shandong First Medical UniversityChronic Coronary Syndrome

Start: 2023-12-18End: 2026-12-31Target: 1200Updated: 2024-04-17

Efficacy and Safety Trials of Yangxinshi Tablets in the Treatment of Patients With Coronary Heart Disease Complicated by Cardiac Dysfunction

RecruitingNCT07110415

SPH Qingdao Growful Pharmacetical Co.,LtdCardiac Dysfunction, Coronary Heart Disease

Start: 2025-11-06End: 2030-12-31Target: 2708Updated: 2025-11-25